Literature DB >> 1543865

Characterization of mucin in the hepatic bile of patients with intrahepatic pigment stones.

T Yamasaki1, F Nakayama, S Tamura, M Endo.   

Abstract

To investigate the relationship between biliary mucin and ductular stone formation, mucin was isolated from hepatic bile using gel filtration on Sepharose CL-4B. The bile was obtained from 14 patients with stones in various sites of the biliary tract. The hexose content in the excluded fraction was significantly higher in patients with intrahepatic ductular stones (68.7 +/- 20.5 micrograms/mL; mean +/- s.d.) than in those with gall-bladder stones or extrahepatic ductular stones (23.8 +/- 8.1 micrograms/mL, 33.3 +/- 9.5 micrograms/mL; P less than 0.05), suggesting a higher concentration of mucin in the bile of patients with intrahepatic ductular stones. Ion-exchange chromatography on DEAE-Sephacel showed that most mucin from each material was negatively charged and electrophoretic studies indicated that it was composed mainly of high molecular weight (greater than 10(6)), sulfated glycoprotein. These results suggested that the mucin content of hepatic bile might have an important relation to the development of intrahepatic ductular stones.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1543865     DOI: 10.1111/j.1440-1746.1992.tb00931.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  Possible role of hepatic bile mucus glycoprotein in development of intrahepatic gallstones.

Authors:  S Akaishi; S Yoshihara; M Sasaki; M Konn
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

2.  Recurrence of intrahepatic stones after an end-to-side choledochojejunostomy.

Authors:  T Akiyama; T Nagakawa; M Kayahara; T Ohta; K Ueno; I Konishi; M Kurachi; I Miyazaki
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

3.  Isolation of mucin from human hepatic bile and its induced effects on precipitation of cholesterol and calcium carbonate in vitro.

Authors:  T Yamasaki; K Chijiiwa; M Endo
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

Review 4.  Significance of controlling chronic proliferative cholangitis in the treatment of hepatolithiasis.

Authors:  Fu Yu Li; Nan Sheng Cheng; Hui Mao; Li Sheng Jiang; Jing Qiu Cheng; Quan Sheng Li; Sanjay Munireddy
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

5.  Treatment of chronic proliferative cholangitis with c-myc shRNA.

Authors:  Fu-Yu Li; Nan-Sheng Cheng; Jing-Qiu Cheng; Hui Mao; Li-Sheng Jiang; Ning Li; Sheng He
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

6.  LPS increases MUC5AC by TACE/TGF-α/EGFR pathway in human intrahepatic biliary epithelial cell.

Authors:  Zipei Liu; Feng Tian; Xiaobin Feng; Yu He; Peng Jiang; Jianwei Li; Fei Guo; Xin Zhao; Hong Chang; Shuguang Wang
Journal:  Biomed Res Int       Date:  2013-08-20       Impact factor: 3.411

7.  Recurrent pyogenic cholangitis: disease characteristics and patterns of recurrence.

Authors:  Ye Xin Koh; Adrian Kah Heng Chiow; Aik Yong Chok; Lip Seng Lee; Siong San Tan; Salleh Ibrahim
Journal:  ISRN Surg       Date:  2013-05-25

8.  MUC Expression in Gallbladder Epithelial Tissues in Cholesterol-Associated Gallbladder Disease.

Authors:  Kyo-Sang Yoo; Ho Soon Choi; Dae Won Jun; Hang Lak Lee; Oh Young Lee; Byung Chul Yoon; Kyeong Geun Lee; Seung Sam Paik; Yong Seok Kim; Jin Lee
Journal:  Gut Liver       Date:  2016-09-15       Impact factor: 4.519

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.